Evie Ring’s Pulse Oximeter Exceeds FDA Accuracy Guidelines in Movano Health’s Second Hypoxia Trial

PLEASANTON, Calif., March 14, 2024 /PRNewswire/ — Movano Health (Nasdaq: MOVE), a pioneer in health technology, has completed another hypoxia trial with the University of California, San Francisco (UCSF) yielding new blood oxygen saturation (SpO2) data, confirming the accuracy of its…

Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks